Remove 2006 Remove Aging and mental health Remove Manufacturing
article thumbnail

Medication Overload, Part II: The Explosion of Drugs for Kids

Mad in America

I n the early 1960s, around the age of two, I experienced an accidental overdose. The incident occurred after one of my preschool-age siblings managed to use a kitchen chair to retrieve the tasty but very toxic medicine, open the bottle, and then give it to me believing the “candy medicine” would help their baby sister feel better.

article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. This applies in the mental illness world and everywhere in medicine. It was a fun thing to do, and we launched it in the British Medical Journal on April 1 st , 2006. I started writing books. What was that about?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Upcoming ECT Legislation Needs to Be Revised

Mad in America

McCarthy Vahey , and distinguished members of the Connecticut Public Health Committee : I am sharing the following information related to H.B. ECT is a psychiatric treatment for clinical depression and other mental health conditions in which electrical impulses are passed through a persons brain to cause brief seizures (Egan, 2018).

article thumbnail

STAR*D: The Harms of Orchestrated Psychiatric Fraud

Mad in America

At a cost of 35 million dollars, NIMH’s STAR*D study, which was published in 2006 , is the most extensive and expensive study ever conducted to determine the effectiveness of drug treatment for depression. We showed how STAR*D’s authors had manipulated the data to manufacture fraudulent results. He, too, was spurned.